4449 Easton Way 2nd Floor43219 Columbus , Ohio
Registration country:United States
Develops endoscopically implantable devices for the treatment of metabolic diseases that include obesity and type 2 diabetes
Founded in 2006, EndoSphere Inc. is a pioneer of endoscopically-insertable medical technologies. The company has developed a portfolio of intellectual property assets including 25 issued and pending U.S. and international patents. Its flagship product, the Satisphere™ System, is a noninvasive treatment for one of the world’s largest health issues: obesity and its co-morbidities. The SatiSphere device improves the regulation of appetite and satiety by using the body’s natural physiology. Use of the device does not require any incision and is reversible and repeatable. Clinical studies have shown that the device enables obese patients to achieve significant weight loss without invasive surgery or medication.